Erratum: Tertiary lymphoid structures in hepatocellular carcinoma: influence on immune cell profiles in tumors and on efficacy of adjuvant PD-1 inhibitor therapy after hepatectomy.
1/5 보강
OpenAlex 토픽 ·
Cancer Immunotherapy and Biomarkers
Hepatocellular Carcinoma Treatment and Prognosis
Immunotherapy and Immune Responses
APA
Jia-Yong Su, Jian-Rong Li, et al. (2026). Erratum: Tertiary lymphoid structures in hepatocellular carcinoma: influence on immune cell profiles in tumors and on efficacy of adjuvant PD-1 inhibitor therapy after hepatectomy.. Hepatology (Baltimore, Md.), 83(5), E155-E157. https://doi.org/10.1097/HEP.0000000000001517
MLA
Jia-Yong Su, et al.. "Erratum: Tertiary lymphoid structures in hepatocellular carcinoma: influence on immune cell profiles in tumors and on efficacy of adjuvant PD-1 inhibitor therapy after hepatectomy.." Hepatology (Baltimore, Md.), vol. 83, no. 5, 2026, pp. E155-E157.
PMID
41995704 ↗
같은 제1저자의 인용 많은 논문 (5)
- Letter: Tumour Burden Score for Predicting Extrahepatic Metastasis in Hepatocellular Carcinoma After Curative Resection.
- Adjuvant Immunotherapy for Hepatocellular Carcinoma: Precision Selection of the Optimal Beneficiary Population as the Core Strategy.
- Tertiary lymphoid structures in HCC: Influence on immune cell profiles in tumors and on efficacy of adjuvant PD-1 inhibitor therapy after hepatectomy.
- Adjuvant Transarterial Chemoembolization After Truly Curative Resection Does Not Improve Survival of Patients With Hepatocellular Carcinoma at High Risk of Recurrence: A Target Trial Emulation Study.
- Treatment Duration of Adjuvant Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Patients at High Risk of Recurrence after Resection: A Prospective, Multicentric Cohort Study.